0001487371-20-000016.txt : 20200123
0001487371-20-000016.hdr.sgml : 20200123
20200123184048
ACCESSION NUMBER: 0001487371-20-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200123
FILED AS OF DATE: 20200123
DATE AS OF CHANGE: 20200123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mitchell Brian Andrew
CENTRAL INDEX KEY: 0001707237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34753
FILM NUMBER: 20543352
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GenMark Diagnostics, Inc.
CENTRAL INDEX KEY: 0001487371
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 272053069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (760) 448-4300
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
wf-form4_157982283113016.xml
FORM 4
X0306
4
2020-01-23
0
0001487371
GenMark Diagnostics, Inc.
GNMK
0001707237
Mitchell Brian Andrew
5964 LA PLACE COURT
CARLSBAD
CA
92008
0
1
0
0
SVP, Operations
Common Stock
2020-01-23
4
M
0
11563
0
A
210310
D
Common Stock
2020-01-23
4
S
0
4993
4.93
D
205317
D
Market Stock Units
0.0
2020-01-23
4
M
0
5347
0
A
Common Stock
5347.0
11305
D
Market Stock Units
0.0
2020-01-23
4
M
0
6216
0
A
Common Stock
6216.0
18784
D
The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units.
The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $4.80 to $5.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
/s/ Eric Stier, Attorney-in-fact
2020-01-23